Changes to the Injeq Plc. Board

The Annual General Meeting held on May 31 2022 made the regular decisions as defined in the by-laws.

The new Board of Directors was elected in the Annual General Meeting and the five members are:

Jari Hyttinen
Tommi Majaus
Tomi Numminen
Tommi Rasila
Pekka Tammela

The new Board had the first meeting On June 8, 2022. Tomi Numminen was elected as the chairman of the Board of Directors and Tommi Rasila was elected as the vice-chair.

More information about the Board members is available on the Finnish – site: https://injeq.com/fi/sijoittajille/hallitus/

FDA grants breakthrough device designation for Injeq IQ-Tip® smart needle

Injeq is happy to announce that Injeq IQ-Tip device with its indications for use meet the criteria and have been […]
Read more »

Breakthrough Device designation granted by FDA

Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »

Injeq grows – new distributor in Hong Kong

Injeq visited Hong Kong in May and met with local hospital management there. The interest towards Injeq IQ-Tip® system convinced […]
Read more »

Large multicenter trial of pediatric hemato-oncology patients sponsored by Injeq

A clinical investigation conducted in all five Finnish university hospitals and sponsored by Injeq has begun in May. A peer-reviewed […]
Read more »

Two more weeks to go!

There are two weeks left in Injeq’s share issue. Read the promising news and invest: Funding: Injeq Oyj (invesdor.com)   […]
Read more »

Injeq IQ-Tip®: Benefits for healthcare and society

Post-dural puncturel headache after lumbar puncture is a difficult post-procedure complication caused by cerebrospinal fluid seeping through the lumbar puncture […]
Read more »

More articles